Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers Tenders > Headlines for 2012 > News item |
Aptalis Pharma announces full redemption of 12¾% senior notes due 2016
By Ashley Montgomery
Kansas City, Kan., May 11 - Aptalis Pharma Inc. has redeemed all of its 12¾% senior notes due 2016, according to an 8-K filing with the Securities and Exchange Commission.
The company said it used cash on hand and term loan borrowings to fund the redemption.
Aptalis is a Bridgewater, N.J.-based specialty pharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.